Last reviewed · How we verify
FDL176 & FDL169 coadministration — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
FDL176 & FDL169 coadministration (FDL176 & FDL169 coadministration) — Flatley Discovery Lab LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| FDL176 & FDL169 coadministration TARGET | FDL176 & FDL169 coadministration | Flatley Discovery Lab LLC | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- FDL176 & FDL169 coadministration CI watch — RSS
- FDL176 & FDL169 coadministration CI watch — Atom
- FDL176 & FDL169 coadministration CI watch — JSON
- FDL176 & FDL169 coadministration alone — RSS
Cite this brief
Drug Landscape (2026). FDL176 & FDL169 coadministration — Competitive Intelligence Brief. https://druglandscape.com/ci/fdl176-fdl169-coadministration. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab